TABLE 6

Neuropsychological Test Results According to Treatment Group (N = 327)

Mean (SD)Adjusted Mean Difference (95% CI)a
IndomethacinPlacebo
WISC-III
    Verbal IQ91.9 (18.2)92.0 (17.6)−1.2 (−4.6 to 2.3)
    Performance IQ86.4 (17.5)88.5 (17.5)−3.2 (−6.8 to 0.5)
    FSIQ88.3 (18.1)89.4 (17.0)−2.3 (−5.7 to 1.2)
Language
    PPVT-R93.2 (23.4)93.2 (24.6)−1.2 (−6.0 to 3.6)
    CTOPP92.7 (20.7)95.4 (20.9)−2.6 (−7.4 to 2.3)
    CELF: total language score85.6 (19.5)87.1 (19.5)−2.1 (−6.1 to 1.9)
    TOWRE: phonemic decoding91.4 (17.7)91.9 (16.9)−0.9 (−4.6 to 2.9)
    TOWRE: sight word efficiency93.1 (16.2)94.8 (15.4)−1.8 (−5.3 to 1.7)
    GSRT89.0 (24.8)90.3 (24.4)−2.3 (−7.4 to 2.9)
  • Indomethacin-by-gender effect: P >.05.

  • a Adjustment for maternal education, minority, and single-parent household.